Major Depressive Disorder Drug Industry Research Report 2025

Summary

According to APO Research, the global Major Depressive Disorder Drug market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Major Depressive Disorder Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Major Depressive Disorder Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Major Depressive Disorder Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Major Depressive Disorder Drug include Eli Lilly and Company, GlaxoSmithKline Plc, Intra-Cellular Therapies, Inc., Hua Medicine Ltd., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd., e-Therapeutics Plc, Cerecor Inc. and Bristol-Myers Squibb Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Major Depressive Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Major Depressive Disorder Drug.

The report will help the Major Depressive Disorder Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Major Depressive Disorder Drug market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Major Depressive Disorder Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Major Depressive Disorder Drug Segment by Company

Eli Lilly and Company
GlaxoSmithKline Plc
Intra-Cellular Therapies, Inc.
Hua Medicine Ltd.
H. Lundbeck A/S
F. Hoffmann-La Roche Ltd.
e-Therapeutics Plc
Cerecor Inc.
Bristol-Myers Squibb Company
Major Depressive Disorder Drug Segment by Type

AV-101
AVP-786
Basimglurant
Aripiprazole
Brexpiprazole
Others
Major Depressive Disorder Drug Segment by Application

Research Center
Hospital
Clinic
Major Depressive Disorder Drug Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East Middle East & Africa
Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Depressive Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Major Depressive Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Depressive Disorder Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Major Depressive Disorder Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Major Depressive Disorder Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Major Depressive Disorder Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Major Depressive Disorder Drug Market Size (2020-2031)
2.2.2 Global Major Depressive Disorder Drug Sales (2020-2031)
2.2.3 Global Major Depressive Disorder Drug Market Average Price (2020-2031)
2.3 Major Depressive Disorder Drug by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 AV-101
2.3.3 AVP-786
2.3.4 Basimglurant
2.3.5 Aripiprazole
2.3.6 Brexpiprazole
2.3.7 Others
2.4 Major Depressive Disorder Drug by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Research Center
2.4.3 Hospital
2.4.4 Clinic
3 Market Competitive Landscape by Manufacturers
3.1 Global Major Depressive Disorder Drug Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Major Depressive Disorder Drug Sales (W Units) of Manufacturers (2020-2025)
3.3 Global Major Depressive Disorder Drug Revenue of Manufacturers (2020-2025)
3.4 Global Major Depressive Disorder Drug Average Price by Manufacturers (2020-2025)
3.5 Global Major Depressive Disorder Drug Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Major Depressive Disorder Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Major Depressive Disorder Drug, Product Type & Application
3.8 Global Manufacturers of Major Depressive Disorder Drug, Established Date
3.9 Global Major Depressive Disorder Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Eli Lilly and Company
4.1.1 Eli Lilly and Company Company Information
4.1.2 Eli Lilly and Company Business Overview
4.1.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Eli Lilly and Company Major Depressive Disorder Drug Product Portfolio
4.1.5 Eli Lilly and Company Recent Developments
4.2 GlaxoSmithKline Plc
4.2.1 GlaxoSmithKline Plc Company Information
4.2.2 GlaxoSmithKline Plc Business Overview
4.2.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.2.4 GlaxoSmithKline Plc Major Depressive Disorder Drug Product Portfolio
4.2.5 GlaxoSmithKline Plc Recent Developments
4.3 Intra-Cellular Therapies, Inc.
4.3.1 Intra-Cellular Therapies, Inc. Company Information
4.3.2 Intra-Cellular Therapies, Inc. Business Overview
4.3.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Product Portfolio
4.3.5 Intra-Cellular Therapies, Inc. Recent Developments
4.4 Hua Medicine Ltd.
4.4.1 Hua Medicine Ltd. Company Information
4.4.2 Hua Medicine Ltd. Business Overview
4.4.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Hua Medicine Ltd. Major Depressive Disorder Drug Product Portfolio
4.4.5 Hua Medicine Ltd. Recent Developments
4.5 H. Lundbeck A/S
4.5.1 H. Lundbeck A/S Company Information
4.5.2 H. Lundbeck A/S Business Overview
4.5.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.5.4 H. Lundbeck A/S Major Depressive Disorder Drug Product Portfolio
4.5.5 H. Lundbeck A/S Recent Developments
4.6 F. Hoffmann-La Roche Ltd.
4.6.1 F. Hoffmann-La Roche Ltd. Company Information
4.6.2 F. Hoffmann-La Roche Ltd. Business Overview
4.6.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.6.4 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Product Portfolio
4.6.5 F. Hoffmann-La Roche Ltd. Recent Developments
4.7 e-Therapeutics Plc
4.7.1 e-Therapeutics Plc Company Information
4.7.2 e-Therapeutics Plc Business Overview
4.7.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.7.4 e-Therapeutics Plc Major Depressive Disorder Drug Product Portfolio
4.7.5 e-Therapeutics Plc Recent Developments
4.8 Cerecor Inc.
4.8.1 Cerecor Inc. Company Information
4.8.2 Cerecor Inc. Business Overview
4.8.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Cerecor Inc. Major Depressive Disorder Drug Product Portfolio
4.8.5 Cerecor Inc. Recent Developments
4.9 Bristol-Myers Squibb Company
4.9.1 Bristol-Myers Squibb Company Company Information
4.9.2 Bristol-Myers Squibb Company Business Overview
4.9.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Bristol-Myers Squibb Company Major Depressive Disorder Drug Product Portfolio
4.9.5 Bristol-Myers Squibb Company Recent Developments
5 Global Major Depressive Disorder Drug Market Scenario by Region
5.1 Global Major Depressive Disorder Drug Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Major Depressive Disorder Drug Sales by Region: 2020-2031
5.2.1 Global Major Depressive Disorder Drug Sales by Region: 2020-2025
5.2.2 Global Major Depressive Disorder Drug Sales by Region: 2026-2031
5.3 Global Major Depressive Disorder Drug Revenue by Region: 2020-2031
5.3.1 Global Major Depressive Disorder Drug Revenue by Region: 2020-2025
5.3.2 Global Major Depressive Disorder Drug Revenue by Region: 2026-2031
5.4 North America Major Depressive Disorder Drug Market Facts & Figures by Country
5.4.1 North America Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Major Depressive Disorder Drug Sales by Country (2020-2031)
5.4.3 North America Major Depressive Disorder Drug Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Major Depressive Disorder Drug Market Facts & Figures by Country
5.5.1 Europe Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Major Depressive Disorder Drug Sales by Country (2020-2031)
5.5.3 Europe Major Depressive Disorder Drug Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Major Depressive Disorder Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Major Depressive Disorder Drug Sales by Country (2020-2031)
5.6.3 Asia Pacific Major Depressive Disorder Drug Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Major Depressive Disorder Drug Market Facts & Figures by Country
5.7.1 South America Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Major Depressive Disorder Drug Sales by Country (2020-2031)
5.7.3 South America Major Depressive Disorder Drug Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Major Depressive Disorder Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Major Depressive Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Major Depressive Disorder Drug Sales by Country (2020-2031)
5.8.3 Middle East and Africa Major Depressive Disorder Drug Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Major Depressive Disorder Drug Sales by Type (2020-2031)
6.1.1 Global Major Depressive Disorder Drug Sales by Type (2020-2031) & (W Units)
6.1.2 Global Major Depressive Disorder Drug Sales Market Share by Type (2020-2031)
6.2 Global Major Depressive Disorder Drug Revenue by Type (2020-2031)
6.2.1 Global Major Depressive Disorder Drug Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Major Depressive Disorder Drug Revenue Market Share by Type (2020-2031)
6.3 Global Major Depressive Disorder Drug Price by Type (2020-2031)
7 Segment by Application
7.1 Global Major Depressive Disorder Drug Sales by Application (2020-2031)
7.1.1 Global Major Depressive Disorder Drug Sales by Application (2020-2031) & (W Units)
7.1.2 Global Major Depressive Disorder Drug Sales Market Share by Application (2020-2031)
7.2 Global Major Depressive Disorder Drug Revenue by Application (2020-2031)
7.2.1 Global Major Depressive Disorder Drug Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Major Depressive Disorder Drug Revenue Market Share by Application (2020-2031)
7.3 Global Major Depressive Disorder Drug Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Major Depressive Disorder Drug Value Chain Analysis
8.1.1 Major Depressive Disorder Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Major Depressive Disorder Drug Production Mode & Process
8.2 Major Depressive Disorder Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Major Depressive Disorder Drug Distributors
8.2.3 Major Depressive Disorder Drug Customers
9 Global Major Depressive Disorder Drug Analyzing Market Dynamics
9.1 Major Depressive Disorder Drug Industry Trends
9.2 Major Depressive Disorder Drug Industry Drivers
9.3 Major Depressive Disorder Drug Industry Opportunities and Challenges
9.4 Major Depressive Disorder Drug Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings